 | Up a level |
Pal, Sumanta K., Rosenberg, Jonathan E., Hoffman-Censits, Jean H., Berger, Raanan, Quinn, David I., Galsky, Matthew D., Wolf, Juergen, Dittrich, Christian, Keam, Bhumsuk, Delord, Jean-Pierre, Schellens, Jan H. M., Gravis, Gwenaelle, Medioni, Jacques, Maroto, Pablo, Sriuranpong, Virote, Charoentum, Chaiyut, Burris, Howard A., Grunwald, Viktor, Petrylak, Daniel, Vaishampayan, Ulka 
ORCID: 0000-0001-5800-4571, Gez, Eliahu, De Giorgi, Ugo, Lee, Jae-Lyun, Voortman, Jens, Gupta, Sumati, Sharma, Sunil, Mortazavi, Amir, Vaughn, David J., Isaacs, Randi, Parker, Katie, Chen, Xueying, Yu, Kun, Porter, Dale, Porta, Diana Graus and Bajorin, Dean F.
(2018).
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations.
Cancer Discov., 8 (7).
S. 812 - 822.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 2159-8290
Sequist, Lecia V., Cassier, Phillippe, Varga, Andrea, Tabernero, Josep, Schellens, Jan H., Delord, Jean-Pierre, LoRusso, Patricia, Camidge, D. Ross, Hidalgo Medina, Manuel, Schuler, Martin, Campone, Mario, Tian, G. Gary, Wong, Steven, Corral, Jesus, Isaacs, Randi, Sen, Suman K., Porta, Diana Graus, Kulkarni, Swarupa G., Lefebvre, Caroline and Wolf, Juergen (2014). Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors. Cancer Res., 74 (19). PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445